<?xml version="1.0" ?>
<TABLE>
<ENTRY>
<ID>CHEBI:10213</ID>
<NAME>alpha-amyrin</NAME>
<DEFINITION>A pentacyclic triterpenoid that is ursane which contains a double bond between positions 12 and 13 and in which the hydrogen at the 3Î² position is substituted by a hydroxy group.</DEFINITION>
<STAR>3</STAR>
<SYNONYM>viminalol</SYNONYM>
<SYNONYM>urs-12-ene-3beta-ol</SYNONYM>
<SYNONYM>alpha-amyrine</SYNONYM>
<SYNONYM>alpha-Amyrin</SYNONYM>
<SYNONYM>Alpha-amyrin</SYNONYM>
<SYNONYM>alpha-amyrenol</SYNONYM>
<SYNONYM>5alpha-urs-12-en-3beta-ol</SYNONYM>
<SYNONYM>4,4,6a,6b,8a,11,12,14b-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-ol</SYNONYM>
<IUPAC_NAME>(3beta)-urs-12-en-3-ol</IUPAC_NAME>
<FORMULA>C30H50O</FORMULA>
<MASS>426.71740</MASS>
<MONOISOTOPIC_MASS>426.38617</MONOISOTOPIC_MASS>
<CHARGE>0</CHARGE>
<SMILES>[H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@]5(C)CC[C@@]34C)[C@@]1(C)CC[C@H](O)C2(C)C</SMILES>
<INCHI>InChI=1S/C30H50O/c1-19-11-14-27(5)17-18-29(7)21(25(27)20(19)2)9-10-23-28(6)15-13-24(31)26(3,4)22(28)12-16-30(23,29)8/h9,19-20,22-25,31H,10-18H2,1-8H3/t19-,20+,22+,23-,24+,25+,27-,28+,29-,30-/m1/s1</INCHI>
<INCHIKEY>FSLPMRQHCOLESF-SFMCKYFRSA-N</INCHIKEY>
<CAS_REGISTRY_NUMBER>638-95-9</CAS_REGISTRY_NUMBER>
<REAXYS_REGISTRY_NUMBER>1916550</REAXYS_REGISTRY_NUMBER>
<CHEMIDPLUS>638-95-9</CHEMIDPLUS>
<KEGG_COMPOUND_ACCESSION>C08615</KEGG_COMPOUND_ACCESSION>
<KNAPSACK_ACCESSION>C00003737</KNAPSACK_ACCESSION>
<LIPID_MAPS_INSTANCE_ACCESSION>LMPR0106170001</LIPID_MAPS_INSTANCE_ACCESSION>
<METACYC_ACCESSION>CPD-8250</METACYC_ACCESSION>
<PUBMED_CITATION>10848960</PUBMED_CITATION>
<PUBMED_CITATION>15626726</PUBMED_CITATION>
<PUBMED_CITATION>15659316</PUBMED_CITATION>
<PUBMED_CITATION>18129592</PUBMED_CITATION>
<PUBMED_CITATION>19488928</PUBMED_CITATION>
<PUBMED_CITATION>21575133</PUBMED_CITATION>
</ENTRY>
</TABLE>
